Cannabidiol (CBD) is slowly but surely making a name for itself as the miracle drug of the decade, if not century. The controversial cannabis extract has powerful medicinal properties that make it effective against a variety of conditions, from chronic pain and high blood pressure to severe forms of childhood epilepsy. With funding from a Toronto animal health company, researchers in Ontario are looking to see if the compound is just as effective against cancer in dogs.
The three-year study is the first of its kind in Canada, and it will try to prove if cannabis can be used to treat canine cancer. In a press release on Tuesday, The University of Guelph’s Ontario Veterinary College (OVC) said the research would “help point the way to alternative pet therapies.” It will focus primarily on CBD’s ability to treat…
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
[email protected]